Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-Vegf Therapy in Fighting Metastatic Colorectal Cancer?
Clinical Colorectal Cancer - United States
doi 10.1016/j.clcc.2017.10.003
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2018
Authors
Publisher
Elsevier BV